Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
NCT03137797 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 800
Last updated 2017-05-03
Summary
The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.
Conditions
- HIV Infection
Sponsors & Collaborators
-
ANRS, Emerging Infectious Diseases
lead OTHER_GOV
Principal Investigators
-
Laurence Meyer, Professor · Institut National de la Santé Et de la Recherche Médicale, France
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- France
Study Locations
More Related Trials
-
Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting
NCT01772940 ·Status: COMPLETED ·Phase: PHASE4
-
D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults
NCT01565850 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Inflammatory Markers and Incidence of Comorbidities in Patients on Antiretroviral Therapy With Second-generation Anti-integrase Drugs on Triple Versus Dual Therapy
NCT05699785 ·Status: RECRUITING ·Phase: NA
-
A Long-term Follow-up of the HIV-NAT Cohort
NCT00411983 ·Status: RECRUITING
-
Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus
NCT00321438 ·Status: TERMINATED
-
A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1
NCT01266902 ·Status: COMPLETED ·Phase: PHASE3
-
Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort
NCT00989144 ·Status: COMPLETED
-
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
NCT01968551 ·Status: COMPLETED ·Phase: PHASE3
-
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy
NCT04448158 ·Status: COMPLETED
-
Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)
NCT00573001 ·Status: COMPLETED ·Phase: PHASE3
-
Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study
NCT01038401 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
NCT01928407 ·Status: COMPLETED ·Phase: PHASE4
-
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
NCT01048671 ·Status: COMPLETED
-
Immuno-virological Evaluation of Persons Living With HIV (PLWH)
NCT05973825 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cohort IMEA 070 -Lenacapavir Compassional
NCT06289361 ·Status: ACTIVE_NOT_RECRUITING
-
Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy
NCT05303337 ·Status: RECRUITING
-
Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants
NCT02269917 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of (D/C/F/TAF) Once Daily Fixed Dose Combination (FDC) Regimen in Newly Diagnosed, Antiretroviral Treatment-naive Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Receiving Care in a Test and Treat Model of Care
NCT03227861 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
NCT00705926 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
NCT01024556 ·Status: COMPLETED
-
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
NCT00196599 ·Status: COMPLETED ·Phase: PHASE2
-
Early ART to Limit Infection and Establishment of Reservoir
NCT02859558 ·Status: COMPLETED ·Phase: PHASE2
-
Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti
NCT00120510 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)
NCT00027352 ·Status: COMPLETED
-
Analytical Treatment Interruption in HIV Positive Patients
NCT02590354 ·Status: COMPLETED ·Phase: NA